季節性インフルエンザ(Seasonal Influenza)：治療薬開発パイプライン動向（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Seasonal Influenza Overview 9
Therapeutics Development 10
Pipeline Products for Seasonal Influenza – Overview 10
Pipeline Products for Seasonal Influenza – Comparative Analysis 11
Seasonal Influenza – Therapeutics under Development by Companies 12
Seasonal Influenza – Therapeutics under Investigation by Universities/Institutes 16
Seasonal Influenza – Pipeline Products Glance 17
Late Stage Products 17
Clinical Stage Products 18
Early Stage Products 19
Seasonal Influenza – Products under Development by Companies 20
Seasonal Influenza – Products under Investigation by Universities/Institutes 24
Seasonal Influenza – Companies Involved in Therapeutics Development 25
AIMM Therapeutics B.V. 25
AltraVax Inc. 26
AmVac AG 27
Baxter International Inc. 28
Big DNA Ltd. 29
BioDiem Ltd 30
Celltrion, Inc. 31
Cilian AG 32
Codagenix, Inc. 33
ContraFect Corporation 34
Crucell N.V. 35
Eurocine Vaccines AB 36
FluGen, Inc. 37
GlaxoSmithKline plc 38
Hemispherx Biopharma, Inc. 39
Inovio Pharmaceuticals, Inc. 40
Johnson & Johnson 41
Liquidia Technologies, Inc. 42
Medicago Inc. 43
Merck & Co., Inc. 44
Novartis AG 45
Novavax, Inc. 46
OPKO Health, Inc. 47
PeptiVir, Inc. 48
Protein Sciences Corporation 49
TechnoVax, Inc. 50
Theraclone Sciences, Inc. 51
Touchlight Genetics Ltd. 52
TSRL, Inc. 53
Vaxart, Inc. 54
Vaxine Pty Ltd 55
VaxInnate Corporation 56
Vivaldi Biosciences Inc. 57
Zydus Cadila Healthcare Limited 58
Seasonal Influenza – Therapeutics Assessment 59
Assessment by Monotherapy Products 59
Assessment by Combination Products 60
Assessment by Target 61
Assessment by Mechanism of Action 63
Assessment by Route of Administration 65
Assessment by Molecule Type 67
Drug Profiles 69
(influenza B virus + influenza A virus [H3N2] + influenza A virus [H1N1]) vaccine – Drug Profile 69
A-06 – Drug Profile 70
Alferon LDO – Drug Profile 71
AMV-401 – Drug Profile 72
BDNA-002 – Drug Profile 73
Bispecific Monoclonal Antibody to Inhibit Hemagglutinin for Seasonal and Pandemic Influenza – Drug Profile 74
CF-404 – Drug Profile 75
CiFlu – Drug Profile 76
CR-8020 – Drug Profile 78
CTP-25 – Drug Profile 80
CTP-27 – Drug Profile 81
FluCell – Drug Profile 82
FVH-1 – Drug Profile 83
IKT-041 – Drug Profile 84
Influ-nRNA – Drug Profile 85
influenza (quadrivalent) vaccine – Drug Profile 86
influenza (split virion, trivalent) vaccine – Drug Profile 88
influenza (trivalent) vaccine – Drug Profile 89
influenza (trivalent) vaccine – Drug Profile 90
influenza (trivalent) vaccine – Drug Profile 91
influenza [A/Christchurch/16/2010 (H1N1) + A/Texas/50/2012 (H3N2) + B/Massachusetts/02/2012 + B/Brisbane/60/2008] (split virion) vaccine – Drug Profile 92
influenza [H1N1] (quadrivalent) virus like particle vaccine – Drug Profile 94
influenza [strain A/H1N1] + [strain A/H3N2] + [strain B] (split virion) vaccine – Drug Profile 96
influenza [strain H1N1] (monovalent) vaccine – Drug Profile 98
influenza vaccine – Drug Profile 100
influenza vaccine – Drug Profile 101
influenza vaccine – Drug Profile 102
influenza vaccine – Drug Profile 104
INO-3510 – Drug Profile 105
LIQ-001 – Drug Profile 106
Monoclonal Antibodies to Inhibit Hemagglutinin for Seasonal Influenza and Pandemic Influenza – Drug Profile 107
NB-1008 – Drug Profile 108
PVI-1000 – Drug Profile 109
respiratory syncytical virus + influenza vaccine – Drug Profile 110
seasonal influenza (quadrivalent) vaccine – Drug Profile 111
seasonal influenza (trivalent) vaccine – Drug Profile 112
seasonal influenza (trivalent) vaccine – Drug Profile 115
seasonal influenza [A/H1N1, A/H3N2, B/Yamagata, B/Victoria] (quadrivalent) vaccine – Drug Profile 116
seasonal influenza [B/Yamagata] (monovalent) vaccine – Drug Profile 117
seasonal influenza [H3N2] vaccine – Drug Profile 118
seasonal influenza B vaccine – Drug Profile 119
seasonal influenza vaccine – Drug Profile 120
seasonal influenza vaccine – Drug Profile 121
seasonal influenza vaccine – Drug Profile 122
seasonal influenza vaccine – Drug Profile 123
Small Molecules for Influenza – Drug Profile 124
Small Molecules to Activate Sirtuin for Influenza – Drug Profile 125
TAK-850 – Drug Profile 126
TCN-032 – Drug Profile 127
TSR-026 – Drug Profile 129
TSR-462 – Drug Profile 130
TVX-001 – Drug Profile 131
VAX-2012Q – Drug Profile 132
VB126 LAIV – Drug Profile 133
VH-244 – Drug Profile 134
VX-787 – Drug Profile 136
VXAA-1.1 – Drug Profile 137
Seasonal Influenza – Recent Pipeline Updates 138
Seasonal Influenza – Dormant Projects 153
Seasonal Influenza – Discontinued Products 155
Seasonal Influenza – Product Development Milestones 156
Featured News & Press Releases 156
Appendix 162
Methodology 162
Coverage 162
Secondary Research 162
Primary Research 162
Expert Panel Validation 162
Contact Us 162
Disclaimer 163